Reagan-Udall Foundation for the FDA

Reagan-Udall Foundation for the FDA We're the FDA's foundation: a nonprofit, created by Congress, helping to modernize regulatory science. We're on it. And you can join us.

What better way to say nonpartisan than for Congress to name us after Ronald Reagan and Mo Udall? Back in 2007 the call to action was to identify, fund, and support projects and programs that help equip FDA staff with the highest caliber science and technology. For example, you can share our newly launched expanded access Navigator website with patients and physicians researching the complexities

of compassionate use. Or if you're a company, list your expanded access policies on the Navigator's Directory or check out our IMEDS public-private partnerships. Other ways to help us help FDA include donations to our Fellowship program or joining us at the first-ever "Innovations in Regulatory Science" Gala. It's all on our site www.reaganudall.org.

Learn more about the Navigator and eRequest app — the Foundation’s programs to help patients access investigational dr...
04/24/2026

Learn more about the Navigator and eRequest app — the Foundation’s programs to help patients access investigational drugs — to see if Expanded Access may be an option for you or a loved one: https://navigator.reaganudall.org

Check out our new summary report: Recommendations for Expanding Regulatory Agility and Evidentiary Integrity in Developi...
04/01/2026

Check out our new summary report: Recommendations for Expanding Regulatory Agility and Evidentiary Integrity in Developing Treatments for Rare Diseases.

We've distilled insights from leaders in medical research, patient advocacy organizations, industry, and regulatory agencies into 20 actionable recommendations to move rare disease drug development from principle to practice.

Read the full report: https://reaganudall.org/publications/recommendations-expanding-regulatory-agility-and-evidentiary-integrity-developing

We appreciate Dr. Phil Febbo, Foundation Vice Chair and Chair of our Governance Committee, connecting with staff this mo...
03/19/2026

We appreciate Dr. Phil Febbo, Foundation Vice Chair and Chair of our Governance Committee, connecting with staff this morning to share his vision for the Foundation's role in continuing to advance regulatory science.

Foundation Director of Communication and Stakeholder Engagement Lea Ann Browning-McNee is excited to immerse in discussi...
03/04/2026

Foundation Director of Communication and Stakeholder Engagement Lea Ann Browning-McNee is excited to immerse in discussions on novel outcome assessments and meaningful patient reported outcomes at the American Society for Experimental Neurotherapeutics Annual Conference.

Address

1333 New Hampshire Avenue NW Suite 420
Washington D.C., DC
20036

Opening Hours

Monday 8:30am - 5pm
Tuesday 8:30am - 5pm
Wednesday 8:30am - 5pm
Thursday 8:30am - 5pm
Friday 8:30am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Reagan-Udall Foundation for the FDA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Reagan-Udall Foundation for the FDA:

Shortcuts

Featured

Share